Forschner, A.
539  Ergebnisse:
Personensuche X
?
1

Exploring 'decision regret' in adjuvant‐treated melanoma pa..:

Grünke, T. ; Reiter, S. ; Meyer, S....
Journal of the European Academy of Dermatology and Venereology.  , 2024
 
?
4

Efficacy of adjuvant immune checkpoint inhibitors pembroliz..:

Gawaz, A. ; Wolff, I. ; Nanz, L...
Cancer Immunology, Immunotherapy.  73 (2024)  9 - p. , 2024
 
?
5

Cutaneous manifestations induced by check point inhibitors ..:

L'Orphelin, J.‐M. ; Cassecuel, J. ; Kandolf, L....
Journal of the European Academy of Dermatology and Venereology.  37 (2023)  8 - p. 1606-1615 , 2023
 
?
7

P22.03.A FEASIBILITY OF AND COMPLIANCE TO ELECTRONIC PATIEN..:

Renovanz, M ; Stange, F ; Dörner, L...
Neuro-Oncology.  25 (2023)  Supplement_2 - p. ii133-ii134 , 2023
 
?
9

Temperature-controlled high-power short-duration ablation w..:

Kottmaier, M. ; Förschner, L. ; Harfoush, N....
Journal of Interventional Cardiac Electrophysiology.  65 (2022)  2 - p. 491-497 , 2022
 
?
11

Prognostic factors in 161 patients with mucosal melanoma: a..:

Sarac, E. ; Amaral, T. ; Keim, U....
Journal of the European Academy of Dermatology and Venereology.  34 (2020)  9 - p. 2021-2025 , 2020
 
?
 
?
15

3323 The GERMELATOX DeCOG-trial: The attitude of German mel..:

Kaehler, K.C. ; Augustin, M. ; Blohme, C....
European Journal of Cancer.  51 (2015)  - p. S671-S672 , 2015
 
1-15